Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls

AIMS: Atrial fibrillation (AF) costs are expected to be substantial, but cost comparisons with the general population are scarce. Using data from the prospective Swiss-AF cohort study and population-based controls, we estimated the impact of AF on direct healthcare costs from the Swiss statutory hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Aebersold, Helena, Foster-Witassek, Fabienne, Serra-Burriel, Miquel, Brüngger, Beat, Aeschbacher, Stefanie, Beer, Jürg-Hans, Blozik, Eva, Blum, Manuel, Bonati, Leo, Conen, David, Conte, Giulio, Felder, Stefan, Huber, Carola, Kuehne, Michael, Moschovitis, Giorgio, Mueller, Andreas, Paladini, Rebecca E, Reichlin, Tobias, Rodondi, Nicolas, Springer, Anne, Stauber, Annina, Sticherling, Christian, Szucs, Thomas, Osswald, Stefan, Schwenkglenks, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503354/
https://www.ncbi.nlm.nih.gov/pubmed/37709325
http://dx.doi.org/10.1136/bmjopen-2023-072080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503354/
https://www.ncbi.nlm.nih.gov/pubmed/37709325
http://dx.doi.org/10.1136/bmjopen-2023-072080

Ejemplares similares